Autres langues TRxADE HEALTH, Inc.

Actions

MEDS

US89846A4058

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 30/04/2024			Varia. 5j.	Varia. 1 janv.
5,96 ^USD	-5,40%		-8,31%	+14,70%

22/04	TRxADE HEALTH, Inc. annonce ses résultats pour l'exercice clos le 31 décembre 2023	CI
06/03	Les plus fortes hausses de la mi-journée	MT

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

TRxADE Health, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Annual Report on Form 10-K	23/04
TRxADE HEALTH, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	22/04
Market Momentum: Analyzing Five Stocks Exhibiting Strong Upward Trends: INBS, MEDS, IFBD, AISP, VTAK	08/03
Top Midday Gainers	06/03
TRxADE Health Shares Soar After Company Says to Pay Special Dividend	06/03
TRxADE Health, Inc. Announces Special Cash Dividend	06/03
Trxade Health, Inc. Announces Special Cash Dividend, Payable on or About March 22, 2024	06/03
Superlatus Foods, Inc. acquired Superlatus, Inc from TRxADE HEALTH, Inc. for $1.	06/03
Recent Market Movers: Healthcare Companies Making Headlines: DYAI, RIGL, ARDX, VERO, MEDS	28/02
Top Premarket Gainers	20/02
Trxade health, Inc files its 3Q 10Q	17/01
TRxADE: Q3 Earnings Snapshot	16/01
TRxADE HEALTH, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	16/01
TRxADE Announces Receipt of Notification of Deficiency from Nasdaq Regarding Requirement to Timely File Quarterly Report on Form 10-Q.	30/11
TrxADE Health, Inc. affirms its commitment to the pharmaceutical space via its subsidiary Trxade, Inc. which operates the pharmaceutical marketplace and added more members in the third quarter of 2023.	17/10/23
TRxADE Health's Superlatus Enters Distribution Deal With Rainforest Distribution	12/10/23
Superlatus Announces Distribution Partnership with North America's Leading Wholesale Distributor and Expanded Points of Retail Sales	12/10/23
TRxADE HEALTH's Superlatus Acquires Spero Foods Assets	04/10/23
Superlatus, Newly Merged with TRxADE HEALTH, Acquires the assets of Spero Foods, a plant-based tech company Disrupting the Dairy and Egg Industry.	04/10/23
TRxADE HEALTH, Inc. announced that it expects to receive $0.29 million in funding	04/10/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues TRxADE HEALTH, Inc.

Actions

MEDS

US89846A4058

Autres langues

Filtres